Clinician

Clinician

Clinician

Accredited Educational Activities

The Art of Ophthalmology Medicine: Individualizing Therapy in Neovascular Age-Related Macular Degeneration in an Era of Expanded Treatment Options

This enduring activity focuses on individualizing therapy for the treatment of neovascular age-related macular degeneration (nAMD) based on patient-, disease-, and treatment-related factors. Listen to a retina expert talk about some of the technological advancements that can help with timely diagnosis and/or effective interval monitoring of nAMD, discuss the benefits and treatment burdens of conventional anti-vascular endothelial growth factor (VEGF) therapies, and compare the safety, efficacy, and durability of established and emerging therapies for patients with nAMD.
Learn More

The RELIEF Initiative: Seeing the Future: Next-Generation Treatment Approaches for DR, AMD and RVO

This enduring activity focuses on the use of next-generation therapies such as gene therapy, biosimilars, advanced delivery systems, artificial intelligence, and advancements in pharmacological treatments, including new molecular targets and therapeutic formulations for the management of patients with diabetic retinopathy, age-related macular degeneration, and retinal vein occlusion. Listen to a retina expert explain the rationale behind these new therapies, as well as the clinical trial data regarding their safety, efficacy, and mechanisms of action to expand treatment options and potentially improve visual outcomes in patients with retinal vascular conditions.
Learn More

IMMERSIVE SIMULATION EXPERIENCE

Vision RELIEF: Navigating Anti-VEGF Treatment Options to Optimize Treatment Individualization

This Immersive Simulation Experience in diabetic retinopathy (DR), neovascular age-related macular degeneration (nAMD) and retinal vein occlusion (RVO) allows learners to engage in clinical decision-making to individualize treatment with anti-vascular endothelial growth factor (anti-VEGF) therapies. By participating in this simulated 3D encounter, you will observe patient-provider interactions and use pertinent information from the patients’ electronic chart to decide the next best course of action at various key points in care, including identifying eyes that may benefit from anti-VEGF treatment, incorporating assessment of efficacy and safety data into treatment decisions, and strategizing changes in treatment approach to achieve optimal outcomes.
Learn More

New Insights on the Diagnosis and Treatment of Age-Related Macular Degeneration

This enduring program targets critical issues in age-related macular degeneration (AMD), including risk for AMD development and progression, how timely diagnosis and treatment can help prevent progression to vision-threatening complications, as well as treatment strategies for AMD. Learn essential elements of assessment and management, as well as clinical trial data on the latest approaches in care, helping to preserve vision in age-related macular degeneration.

Learn More

A Close Look at the Diagnosis and Treatment of Patients with Retinal Vascular Disease

This online activity targets healthcare gaps related to the diagnosis and management of diabetic retinopathy (DR), age-related macular degeneration (AMD), and retinal vein occlusion (RVO), impacting outcomes through risk stratification, diagnostic strategies, and treatment individualization with anti-VEGF agents.

Learn More

CLICK ON STATES TO SEE LIVE ACTIVITIES

BOOTH TOUR

[ai1ec cat_name=”Booth” ]

ONLINE ACTIVITIES

[ai1ec cat_name=”Online Programs” ]

AMD GRAND ROUNDS

[ai1ec cat_name=”Grand Rounds” ]
[ai1ec cat_name=”MEDS Meetings” ]

A Virtual Reality Learning Experience: Integrating GLP-1 Receptor Agonists into T2DM Practice—Why, When, and How

[ai1ec cat_name=”NACE Meetings” ]
[ai1ec cat_name=”PriMed Booths” ]

Accreditation Statement
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

This activity is provided by Med Learning Group.
This activity is supported by an educational grant from Regeneron Pharmaceuticals, Inc.

Copyright © 2019Med Learning Group. Built by Divigner. All Rights Reserved.

Font Size

A Decrease font size. A Reset font size. A Increase font size.

Scientific Council

Pin It on Pinterest

Directory

Scientific Council

Neil M. Bressler, MD

James P. Gills Professor of Ophthalmology
Professor of Ophthalmology, Johns Hopkins University School of Medicine
Wilmer Eye Institute, Johns Hopkins Medicine
Baltimore, MD

A. Paul Chous, MA, OD, FAAO

Specializing in Diabetes Eye Care & Education, Chous Eye Care Associates
Adjunct Professor of Optometry, Western University of Health Sciences
AOA Representative, National Diabetes Education Program
Tacoma, WA

Steven Ferrucci, OD, FAAO

Chief of Optometry, Sepulveda VA Medical Center
Professor, Southern California College of Optometry at Marshall B. Ketchum University
Sepulveda, CA

Julia A. Haller, MD

Ophthalmologist-in-Chief
Wills Eye Hospital
Philadelphia, PA

Allen C. Ho, MD, FACS

Director, Retina Research
Wills Eye Hospital
Professor and Chair of the Department of Ophthalmology
Thomas Jefferson University Hospitals
Philadelphia, PA

Charles C. Wykoff, MD, PhD

Director of Research, Retina Consultants of Houston
Associate Professor of Clinical Ophthalmology
Blanton Eye Institute & Houston Methodist Hospital
Houston, TX

Back to Portal
Scientific Council

Copyright © 2020 | AMD Relief | All Rights Reserved | Website by Divigner

Clinician Scientific & Educational Resources

The RELIEF Clinical Toolkit is an online tool that aims to provide clinicians with up-to-date information on the presentation, prognosis, pathophysiology, and treatment strategies for age-related macular degeneration (AMD). Click on one of the options below to learn more about AMD.

HD Visual Learning

  • Dynamic, specialty-tailored HD animations about AMD
  • Interactive, downloadable learning tools for mobile devices
  • Immersive learning in the Virtual Reality Room Experience

Pathophysiology

Toolkit description here

Diagnosis and Associated Risk Factors

Toolkit description here

AMD Management

Toolkit description here

Current and Emerging Treatment

Toolkit description here

Find a Clinical Trial

Reading and Resources

Toolkit description here

This activity is provided by Med Learning Group.
This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.

Copyright © 2019 | AMD Relief | All Rights Reserved | Website by Divigner